Company Overview
Universal Health Realty Income Trust operates as a real estate investment trust focused on acquiring and managing healthcare and human-service related facilities, which include acute care hospitals, behavioral health care hospitals, specialty facilities, medical and office buildings, free-standing emergency departments, and childcare centers. The company functions within the broader Real Estate sector and specifically within the REIT - Healthcare Facilities industry, a classification that denotes its primary reliance on generating income through the leasing of properties to healthcare providers rather than providing direct medical services. Regarding its scale, the entity holds a market capitalization of $552.21M and reported annual revenue of $100.89M, though the specific employee count is not disclosed in available data. These financial figures indicate that the company maintains a mid-cap status within the specialized healthcare real estate niche, positioning it as a significant but not dominant player relative to the largest national hospital REITs, with its revenue stream derived entirely from its real estate portfolio rather than operational healthcare services.
Financial Health
The company generated revenue of $100.89M over the trailing twelve months, resulting in a net income of $17.61M and an EBITDA of $66.05M, revealing a substantial gap between operating earnings and bottom-line profit that highlights a significant cost structure dominated by interest expenses and corporate overhead. This disparity between the $66.05M EBITDA and the $17.61M net income underscores the heavy burden of debt servicing costs inherent in the REIT model, where interest payments significantly compress the final profit available to shareholders. The business maintains a free cash flow of $45.65M, which represents the cash remaining after capital expenditures and operating expenses, providing the necessary liquidity to fund future acquisitions or pay dividends without requiring external equity financing. Three key margin metrics further delineate the company's profitability: a gross margin of 94.5% indicates that the majority of revenue remains after covering the direct costs of leasing, while an operating margin of 39.6% reflects the efficiency of managing property-level expenses, and a profit margin of 17.5% shows the final return on each dollar of sales after all costs including debt service. On the balance sheet, the company holds $8.29M in cash against total debt of $386.03M, resulting in a debt-to-equity ratio of 253.33, which suggests a highly leveraged capital structure typical of REITs but one that leaves little room for error in refinancing scenarios. Liquidity is supported by a current ratio of 7.80, indicating that the company possesses ample current assets to cover its short-term liabilities, suggesting a strong ability to meet obligations as they come due. Additionally, the return on equity stands at 10.6% while the return on assets is 4.1%, metrics that reveal management's effectiveness in generating returns on shareholder capital versus the total asset base, with the lower ROA reflecting the impact of high leverage on overall asset efficiency.
Valuation Assessment
Valuation metrics for the stock include a trailing P/E ratio of 31.34 and a forward P/E of N/A, where the absence of a forward P/E prevents a direct comparison of expected earnings trajectory but implies that market expectations for future earnings growth may differ from current performance or that analysts have not yet projected significant near-term changes. The price-to-book ratio is 3.62, indicating that the market values the company at a significant premium over its book value, which is common for asset-heavy REITs with stable, long-term leases that are not fully reflected on the balance sheet. Alternative valuation measures such as a price-to-sales ratio of 5.47 and an EV/EBITDA of 14.08 provide additional context, suggesting that the market is willing to pay a multiple of over five times sales and fourteen times earnings before interest, taxes, depreciation, and amortization, reflecting confidence in the stability of the underlying healthcare assets. Price action over the past year has seen the stock trade between a 52-week high of $44.70 and a 52-week low of $35.26, placing the current trading price within a range that reflects volatility but maintains a distance from the recent peak. The beta of 0.89 indicates that the stock exhibits lower volatility than the broader market, moving with slightly less intensity than the S&P 500, which may offer a degree of defensive characteristic suitable for a healthcare-focused investment vehicle.
Growth & Income
Growth metrics show revenue growth of 0.0% year-over-year and earnings growth of -8.1% year-over-year, indicating that earnings are shrinking relative to revenue, which implies a compression in profitability or a one-time adjustment rather than an expansion in the underlying business volume. The company distributes a dividend yield of 7.5%, supported by a payout ratio of 233.1%, a figure that exceeds 100% and indicates that the company is paying out more in dividends than its reported net income, a practice often sustained by using cash flow or debt principal repayments to fund distributions. Given the payout ratio exceeding earnings, the sustainability of this yield relies heavily on the company's free cash flow generation and the ability to maintain asset values, rather than relying solely on accounting earnings growth. In summary, the company presents a profile of stable income generation with a high dividend yield but limited organic growth, characterized by flat revenue and declining earnings alongside a leveraged balance sheet that supports current distributions but limits capital for aggressive expansion.